Sign Up to like & get
recommendations!
0
Published in 2025 at "Clinical Cardiology"
DOI: 10.1002/clc.70065
Abstract: Finerenone, a nonsteroidal mineralocorticoid receptor antagonist, has emerged as a novel therapeutic option for the management of patients with diabetes, chronic kidney disease, or heart failure. We seek to summarize the evidence on the drug's…
read more here.
Keywords:
meta analysis;
finerenone meta;
safety finerenone;
finerenone ... See more keywords